Mammomat B.brilliant Contrast-Enhanced Mammography, Biopsy Earns FDA Clearance

The FDA has cleared new contrast-enhanced mammography (CEM) and CEM biopsy capabilities for Siemens Healthineers' Mammomat B.brilliant mammography system. This approval expands the clinical capabilities of the imaging platform for breast cancer detection and diagnosis.